Webinar | Cell and gene therapies: Clinical supply chain considerations
Key elements to consider during clinical development for an optimal cell and gene therapy supply chain and tracking outcomes
Moving healthcare forward
When healthcare advances, so must the processes to connect patients to the therapies they need. And because a rapidly changing cell and gene therapy industry requires an equally innovative partner, AmerisourceBergen is committed to delivering solutions that enable this connection.
Let’s build the future together.